These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Domperidone, a new dopamine antagonist. Champion MC; Hartnett M; Yen M CMAJ; 1986 Sep; 135(5):457-61. PubMed ID: 3527396 [TBL] [Abstract][Full Text] [Related]
24. [Nocturnal spasmodic cough in the infant. Evolution after antireflux treatment]. Dordal MT; Baltazar MA; Roca I; Marques L; Server MT; Botoy J Allerg Immunol (Paris); 1994 Feb; 26(2):53-8. PubMed ID: 8148045 [TBL] [Abstract][Full Text] [Related]
27. [Study on relationship between the reflux laryngitis and gastroesophageal reflux disease]. Gong Q; Zhou K Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 15(12):548-9. PubMed ID: 12541725 [TBL] [Abstract][Full Text] [Related]
28. Outcome of laparoscopic Nissen-Rossetti fundoplication in children with gastroesophageal reflux disease and supraesophageal symptoms. Mattioli G; Sacco O; Gentilino V; Martino F; Pini Prato A; Castagnetti M; Montobbio G; Jasonni V Surg Endosc; 2004 Mar; 18(3):463-5. PubMed ID: 14752641 [TBL] [Abstract][Full Text] [Related]
29. Clinical efficacy of proton pump inhibitor therapy in neurologically impaired children with gastroesophageal reflux: prospective study. Cheung KM; Tse PW; Ko CH; Chan YC; Leung CY; Chan KH Hong Kong Med J; 2001 Dec; 7(4):356-9. PubMed ID: 11773669 [TBL] [Abstract][Full Text] [Related]
30. Rabeprazole plus domperidone: the answer for gastro-oesophageal reflux disease. Shahani S; Sawant P; Dabholkar P J Indian Med Assoc; 2008 Apr; 106(4):264, 266, 268. PubMed ID: 18828350 [TBL] [Abstract][Full Text] [Related]
31. Question 2. How effective is domperidone at reducing symptoms of gastro-oesophageal reflux in infants? Scott B Arch Dis Child; 2012 Aug; 97(8):752-5. PubMed ID: 22859430 [No Abstract] [Full Text] [Related]
32. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents. McCallum RW Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702 [TBL] [Abstract][Full Text] [Related]
34. Nissen fundoplication and gastrostomy in severely neurologically impaired children with gastroesophageal reflux. Cheung KM; Tse HW; Tse PW; Chan KH Hong Kong Med J; 2006 Aug; 12(4):282-8. PubMed ID: 16912355 [TBL] [Abstract][Full Text] [Related]
35. [Gastroesophageal reflux in the newborn]. Urrusti-Sanz J Gac Med Mex; 1995; 131(5-6):601-3. PubMed ID: 8768609 [No Abstract] [Full Text] [Related]
36. A diagnostic approach to vomiting in severely retarded patients. Byrne WJ; Campbell M; Ashcraft E; Seibert JJ; Euler AR Am J Dis Child; 1983 Mar; 137(3):259-62. PubMed ID: 6823924 [TBL] [Abstract][Full Text] [Related]
37. QT interval prolongation associated with the oral use of domperidone in an infant. Rocha CM; Barbosa MM Pediatr Cardiol; 2005; 26(5):720-3. PubMed ID: 15690231 [TBL] [Abstract][Full Text] [Related]
38. Prokinetic therapy for gastroesophageal reflux disease. Robinson M Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432 [TBL] [Abstract][Full Text] [Related]
39. Domperidone drops in the symptomatic treatment of chronic paediatric vomiting and regurgitation. A comparison with metoclopramide. De Loore I; Van Ravensteyn H; Ameryckx L Postgrad Med J; 1979; 55 Suppl 1():40-2. PubMed ID: 382154 [TBL] [Abstract][Full Text] [Related]
40. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride. Halter F; Staub P; Hammer B; Guyot J; Miazza BM J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]